Cancer Cells Adapt to SWI/SNF Inhibition through Compensatory EP400 Function

Article navigation

Research Watch| January 12 2024

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2023

American Association for Cancer Research

Cancer Discov (2024) 14 (1): OF9.

Abstract

Loss of the compensatory chromatin remodeler EP400 sensitizes cancer cells to SWI/SNF inhibition.

2023

American Association for Cancer Research

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.